Peptides vs. Vitamin C: Why I Refuse to Choose Sides

The Industry Keeps Asking the Wrong Question

Every time I see a headline framing peptides vs. vitamin C serum efficacy as a binary choice, I know a marketing team — not a formulator — wrote it. The "peptides vs. vitamin C" construct sells serum slots. It does not reflect how either ingredient class actually works at the molecular level, and it does not produce better skin outcomes for the person reading the article.

The pattern is predictable. A new peptide ingredient gets Allure coverage. Within two weeks, there are listicles positioning it against vitamin C as though the two compete at the same receptor, through the same pathway, for the same substrate. They don't. I formulate peptide systems — they're in my Corrective Eye Cream and HYPER Lift — and I also formulate pure L-ascorbic acid serums. Having a front-row seat to both formulation processes makes the "pick one" framing look exactly as reductive as it is.

What Peptides Actually Do — and What They Cannot Do

Signal peptides such as Palmitoyl Oligopeptide and Acetyl Hexapeptide-8 operate through receptor-mediated pathways. They modulate fibroblast behavior and, in the case of acetyl hexapeptide-8, influence neuromuscular signaling at the level of SNARE protein complex formation. That is a meaningful and legitimate mechanism. It is also completely distinct from antioxidant chemistry.

Peptides do not neutralize reactive oxygen species. They do not reverse UV-induced oxidative crosslinking of dermal proteins. They have no demonstrated tyrosinase-inhibition activity at cosmetic use concentrations. I am not diminishing peptides when I say this — I am describing their mechanism accurately, which is the only way to deploy them intelligently.

The clinical evidence base for peptides, while genuinely growing, remains thinner and harder to compare across studies than the decades of published data on topical L-ascorbic acid. The peer-reviewed science on topical vitamin C — including the research that informed Phyto-C's founding formulation science — has been accumulating in journals like the Journal of the American Academy of Dermatology since the 1990s. That asymmetry matters when you're advising an aesthetic professional on what to anchor a protocol around.

What L-Ascorbic Acid Does That No Peptide Can Replicate

Pure L-ascorbic acid at low pH is the only topical vitamin C form with replicated, peer-reviewed clinical data demonstrating collagen gene upregulation, melanogenesis inhibition through tyrosinase suppression, and direct antioxidant quenching of UV-generated free radicals. That is not a marketing claim — it is a summary of the published literature, and it is why I formulate only with L-ascorbic acid and reject vitamin C derivatives as inadequate substitutes. The bioavailability data on ascorbyl glucoside, sodium ascorbyl phosphate, and similar derivatives is weak at best. They require enzymatic or hydrolytic conversion steps that the skin does not reliably perform at therapeutically relevant rates.

The mechanism of L-ascorbic acid is electrochemical. Ascorbate donates electrons to neutralize oxidized lipids and proteins — quenching free radical chain reactions before they propagate through membrane structures. No peptide sequence performs this function. The two ingredient classes are not competitors; they are operating in entirely different chemical theaters.

Stability is the real gating factor for L-ascorbic acid, and it is where most vitamin C serums on the market fail before the consumer even opens the bottle. Without correct pH — I target the 2.5 to 3.5 range — and a formulation architecture that limits oxygen exposure, pure LAA degrades into ascorbic acid oxidation products, which contribute no antioxidant benefit and may introduce pro-oxidant byproducts. I solved this empirically, before the cosmetic chemistry literature had caught up to the formulation challenge. The stabilization approach I use is proprietary, and I will not detail it here, but the principle is not optional: if your vitamin C serum doesn't hold at the right pH under the right conditions, it is not delivering what the label claims.

I also want to be direct about ferulic acid, because I know it is frequently cited as a vitamin C stabilizer. I have never used it in any Phyto-C formula. Research published by Lee in 2005 in the Archives of Pharmacal Research demonstrated NADPH oxidase-mediated ROS generation associated with ferulic acid. That pro-oxidant risk profile is not acceptable to me in a formula built around antioxidant delivery. The industry's enthusiasm for ferulic acid does not change that assessment.

Why I Formulate With Both — and How I Keep Them from Fighting

The compatibility concern between peptides and L-ascorbic acid is real, but it is consistently overstated in consumer media. The practical problem is not that these ingredient classes are fundamentally incompatible — it is that the low-pH environment required for L-ascorbic acid bioavailability can hydrolyze certain peptide bonds over time when both are present in the same vessel. In a single formulation, you are forced to compromise: either raise the pH to protect peptide integrity and sacrifice LAA bioavailability, or maintain the low pH and watch peptide efficacy erode on the shelf.

My solution is functional separation. Pure LAA serums — Serum Twenty, Serum Fifteen, and E in C Advanced — are formulated at their required pH to deliver L-ascorbic acid at full bioavailability. Peptide systems like the Corrective Eye Cream and HYPER Lift operate at a pH range appropriate for peptide integrity and stability. The consumer applies them sequentially, which is also how the skin receives them — one layer at a time, each at its optimal conditions.

This is not a limitation in the product line. It is rational pharmaceutical formulation logic. The same principle governs why you do not combine an acid and a base in a single vial and expect both to function as designed. Separation is the answer, and sequential application is the delivery method.

What I Tell Aesthetic Professionals Who Ask Me to Pick One

My answer is always the same: define the goal first. If the priority is antioxidant support, UV-damage mitigation, and pigmentation correction — pure L-ascorbic acid is non-negotiable. Peptides are additive in that context, not substitutes.

If the priority is targeted neuromodulatory support or matrix-remodeling activity, and the individual is already on a stable vitamin C routine, then layering a peptide treatment on top is a rational next step. The instruction is "layer on top," not "swap out." The distinction matters clinically.

The "which one works" question is a consumer-media simplification. The clinical question is always: works for what, at what concentration, at what pH, in what vehicle, in what sequence? That requires a formulator's answer. Influencer content cannot provide one.

Frequently Asked Questions

Can I use a peptide serum and a vitamin C serum in the same routine?

In my view, yes — and sequential application is the correct approach. Apply your pure L-ascorbic acid serum first, allow it to absorb fully, and then follow with your peptide product. This preserves the pH requirements of each ingredient class and avoids the hydrolytic degradation that can occur when they share the same low-pH environment over time.

Does vitamin C break down peptides in a formula?

The low-pH environment required for L-ascorbic acid bioavailability — ideally 2.5 to 3.5 — can hydrolyze certain peptide bonds when both are present in a single vessel over the product's shelf life. This is not an instantaneous reaction, but it is a real formulation constraint. It is the primary reason I keep them in functionally separated products rather than attempting a combined formula.

Why does Phyto-C keep peptides and vitamin C in separate products instead of one combined serum?

Because formulating them together requires compromising the pH of one or both ingredient classes, and I am not willing to do that. A combined serum either sacrifices L-ascorbic acid bioavailability by raising the pH to protect peptides, or it exposes peptides to conditions that degrade them on the shelf. Separation is not a product-line decision — it is a chemistry decision.

Are vitamin C derivatives like ascorbyl glucoside equivalent to pure L-ascorbic acid for anti-aging support?

From my experience and my reading of the published literature, they are not equivalent. Derivatives require enzymatic or hydrolytic conversion in the skin to produce free ascorbic acid, and the evidence that this conversion occurs at rates sufficient to deliver meaningful antioxidant activity is weak. I formulate exclusively with pure L-ascorbic acid because it is the form with replicated, peer-reviewed clinical data. Derivatives are, in my view, a formulation convenience that trades efficacy for stability.

What concentration of vitamin C serum is clinically meaningful for anti-aging?

The peer-reviewed literature, including foundational research that informed Phyto-C's formulation science, supports concentrations in the range of 15 to 20 percent pure L-ascorbic acid as clinically active for collagen gene upregulation and antioxidant activity. Concentrations below 10 percent show diminishing returns in the published data. Above 20 percent, tolerability becomes the limiting factor for most individuals without a proportional gain in activity. Concentration without pH control, however, is meaningless — the delivery environment determines whether any concentration reaches its target.

The peptides vs. vitamin C serum debate will keep generating clicks, but it will not generate better skin outcomes until it is replaced by a more precise question: what does each ingredient do mechanistically, and how do you deliver both at their optimal conditions? That is the question I answer every time I formulate. If you want to see what those answers look like in practice, the Phyto-C line is a direct reflection of them.